The Human Phenotype Ontology in 2021

2020 Nucleic Acids Research 1,149 citations

Abstract

Abstract The Human Phenotype Ontology (HPO, https://hpo.jax.org) was launched in 2008 to provide a comprehensive logical standard to describe and computationally analyze phenotypic abnormalities found in human disease. The HPO is now a worldwide standard for phenotype exchange. The HPO has grown steadily since its inception due to considerable contributions from clinical experts and researchers from a diverse range of disciplines. Here, we present recent major extensions of the HPO for neurology, nephrology, immunology, pulmonology, newborn screening, and other areas. For example, the seizure subontology now reflects the International League Against Epilepsy (ILAE) guidelines and these enhancements have already shown clinical validity. We present new efforts to harmonize computational definitions of phenotypic abnormalities across the HPO and multiple phenotype ontologies used for animal models of disease. These efforts will benefit software such as Exomiser by improving the accuracy and scope of cross-species phenotype matching. The computational modeling strategy used by the HPO to define disease entities and phenotypic features and distinguish between them is explained in detail.We also report on recent efforts to translate the HPO into indigenous languages. Finally, we summarize recent advances in the use of HPO in electronic health record systems.

Keywords

BiologyPhenotypeComputational biologyOntologyGeneticsVirologyGene

Affiliated Institutions

Related Publications

Publication Info

Year
2020
Type
article
Volume
49
Issue
D1
Pages
D1207-D1217
Citations
1149
Access
Closed

External Links

Social Impact

Altmetric

Social media, news, blog, policy document mentions

Citation Metrics

1149
OpenAlex

Cite This

Sebastian Köhler, Michael Gargano, Nicolas Matentzoglu et al. (2020). The Human Phenotype Ontology in 2021. Nucleic Acids Research , 49 (D1) , D1207-D1217. https://doi.org/10.1093/nar/gkaa1043

Identifiers

DOI
10.1093/nar/gkaa1043